Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07350486

LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia

A Cluster-Randomized Trial of Large Language Model-Enabled Coordinated Management for Hypertension, Diabetes, and Dyslipidemia in Community Settings (LLM-CoManage Trial)

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
6,000 (estimated)
Sponsor
First Hospital of China Medical University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.

Conditions

Interventions

TypeNameDescription
OTHERLLM-Enabled Clinician-Patient Co-managementThe intervention is a LLM-enabled, community-based integrated management strategy for cardiometabolic multimorbidity. The LLM system functions as the central intelligence layer, integrating multi-condition clinical information, delivering real-time decision support, coordinating care workflows, and facilitating continuous patient engagement. Within this LLM-enabled framework, community physicians-after standardized training-serve as the core executors of care, delivering guideline-based pharmacologic treatment, lifestyle counseling, and structured monitoring of coexisting cardiometabolic conditions. Policy-aligned performance incentives are used to support physician engagement and implementation fidelity, without altering medication access or underlying clinical protocols. The LLM-enabled intervention is implemented through the HyperMind system, an integrated platform that simultaneously supports clinicians, patients, and health-system oversight.

Timeline

Start date
2026-06-15
Primary completion
2027-06-30
Completion
2027-12-31
First posted
2026-01-20
Last updated
2026-01-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07350486. Inclusion in this directory is not an endorsement.